BKV legal chief sells 10,000 shares at $26.1613

BKV Corp insider Lindsay B. Larrick, Chief Legal and Admin Officer, reported a sale of 10,000 shares of common stock on August 14, 2026 in an open-market or private transaction.

Rhea-AI Filing Summary

BKV Corp insider Lindsay B. Larrick, Chief Legal and Admin Officer, reported a sale of 10,000 shares of common stock on August 14, 2026 in an open-market or private transaction. The weighted average sale price was $26.1613 per share, with individual trades executed between $25.92 and $26.395 per share. Following this transaction, Larrick directly holds 83,925 shares of BKV common stock. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on May 12, 2026.

Insider Trade Summary 10b5-1

Net Seller: 10,000 shares

Net Sell 1 txn

Insider Larrick Lindsay B

Role Chief Legal and Admin Officer

Sold 10,000 shs ($262K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2	10,000	$26.1613	$262K

Holdings After Transaction: Common Stock — 83,925 shares (Direct)

Footnotes (2)

1. F1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2026.
2. F2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.9200 to $26.3950, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 10,000 shares Weighted average sale price: $26.1613 per share Sale price range: $25.9200–$26.3950 per share +3 more

6 metrics

Shares sold 10,000 shares Common stock sale on August 14, 2026

Weighted average sale price $26.1613 per share Average price for the 10,000 shares sold

Sale price range $25.9200–$26.3950 per share Range of prices for multiple sale transactions

Shares owned after transaction 83,925 shares Directly held BKV common stock following the sale

Net shares sold per summary 10,000 shares Net-sell direction in transaction summary

10b5-1 plan adoption date May 12, 2026 Date Larrick adopted the Rule 10b5-1 trading plan

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, open market or private transaction

3 terms

Rule 10b5-1 trading plan regulatory

"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"The price reported in Column 4 is a weighted average sale price"

open market or private transaction financial

"Sale in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did BKV (BKV) report for Lindsay B. Larrick?

BKV reported that Lindsay B. Larrick sold 10,000 shares of BKV common stock on August 14, 2026. The transaction was a reported open-market or private sale under a Rule 10b5-1 trading plan adopted on May 12, 2026.

At what price were the BKV (BKV) shares sold in Larrick’s Form 4 filing?

The filing shows a weighted average sale price of $26.1613 per BKV share. The 10,000 shares were sold in multiple trades at prices ranging from $25.92 to $26.395, and detailed price breakdowns are available on request from the parties listed.

How many BKV (BKV) shares does Lindsay B. Larrick hold after the reported sale?

After the reported transaction, Lindsay B. Larrick directly holds 83,925 shares of BKV common stock. This figure reflects the position following the 10,000-share sale on August 14, 2026, as reported in the Form 4 insider filing.

Was the BKV (BKV) insider sale by Larrick made under a Rule 10b5-1 plan?

Yes, the sale was effected under a Rule 10b5-1 trading plan adopted by Lindsay B. Larrick on May 12, 2026. The filing’s footnote specifies that the reported transaction was executed pursuant to this pre-arranged trading plan.

What is the size of the net share change in BKV (BKV) from Larrick’s transaction?

The net change from the reported transaction is a disposition of 10,000 shares of BKV common stock. Transaction summary data classifies it as a net-sell event, with no corresponding purchases or derivative exercises reported in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 11:24 AM Accepted by SEC EDGAR 08/17/2026 - 11:24 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Larrick Lindsay B

(Last) (First) (Middle)

1200 17TH STREET, SUITE 2100

(Street)

DENVER COLORADO 80202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BKV Corp [ BKV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal and Admin Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/14/2026		S(1)		10,000	D	$26.1613(2)	83,925	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2026.

2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.9200 to $26.3950, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Kathleen Lenox, attorney-in-fact	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)